602 related articles for article (PubMed ID: 11207050)
1. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
3. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities.
Graadt van Roggen JF; Mooi WJ; Hogendoorn PC
J Pathol; 1998 Sep; 186(1):3-7. PubMed ID: 9875133
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
[TBL] [Abstract][Full Text] [Related]
5. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript.
Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Iwata J; Furihata M; Ohtsuki Y
J Pathol; 1999 Apr; 187(5):594-7. PubMed ID: 10398127
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
Lyle PL; Amato CM; Fitzpatrick JE; Robinson WA
Am J Surg Pathol; 2008 Jun; 32(6):858-66. PubMed ID: 18408594
[TBL] [Abstract][Full Text] [Related]
8. Clear cell sarcoma of soft tissue: diagnostic utility of fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction.
Curry CV; Dishop MK; Hicks MJ; Naeem R; Reed JA; López-Terrada DH
J Cutan Pathol; 2008 Apr; 35(4):411-7. PubMed ID: 18333903
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.
Speleman F; Delattre O; Peter M; Hauben E; Van Roy N; Van Marck E
Mod Pathol; 1997 May; 10(5):496-9. PubMed ID: 9160316
[TBL] [Abstract][Full Text] [Related]
10. Clear cell tumors of the somatic soft tissues.
d'Amore ES; Ninfo V
Semin Diagn Pathol; 1997 Nov; 14(4):270-80. PubMed ID: 9383826
[TBL] [Abstract][Full Text] [Related]
11. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma of soft parts: a rare entity with a specific genetic marker.
Albert MV; Verdeguer A; Fernández JM; Castel V; Hernández M; Oltra JS
Pediatr Blood Cancer; 2006 May; 46(5):659. PubMed ID: 16261586
[No Abstract] [Full Text] [Related]
13. Clear cell sarcoma case report: complex karyotype including t(12;22) in primary and metastatic tumor.
Henkle CT; Hawkins AL; McCarthy EF; Griffin CA
Cancer Genet Cytogenet; 2004 Feb; 149(1):63-7. PubMed ID: 15104285
[TBL] [Abstract][Full Text] [Related]
14. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
Patel RM; Downs-Kelly E; Weiss SW; Folpe AL; Tubbs RR; Tuthill RJ; Goldblum JR; Skacel M
Mod Pathol; 2005 Dec; 18(12):1585-90. PubMed ID: 16258500
[TBL] [Abstract][Full Text] [Related]
15. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
[TBL] [Abstract][Full Text] [Related]
16. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
[TBL] [Abstract][Full Text] [Related]
17. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
18. Clear cell sarcoma of tendons and aponeuroses, and osteoclast-rich tumour of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: a review and update.
Kosemehmetoglu K; Folpe AL
J Clin Pathol; 2010 May; 63(5):416-23. PubMed ID: 20418233
[TBL] [Abstract][Full Text] [Related]
19. Clear cell sarcoma of tendons and aponeuroses with t(12;22) (q13;q12) diagnosed initially as malignant melanoma.
Nedoszytko B; Mrózek K; Roszkiewicz A; Kopacz A; Swierblewski M; Limon J
Cancer Genet Cytogenet; 1996 Oct; 91(1):37-9. PubMed ID: 8908164
[TBL] [Abstract][Full Text] [Related]
20. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
